AIP mutation in pituitary adenomas in the 18th century and today.

AIP mutation in pituitary adenomas in the 18th century and today.

Gigantism results when a growth hormone-secreting pituitary adenoma is present before epiphyseal fusion. In 1909, when Harvey Cushing examined the skeleton of an Irish patient who lived from 1761 to 1783, he noted an enlarged pituitary fossa. We extracted DNA from the patient's teeth and identi...

Descripció completa

Dades bibliogràfiques
Autors principals:	Chahal, H, Stals, K, Unterländer, M, Balding, D, Thomas, MG, Kumar, A, Besser, G, Atkinson, AB, Morrison, P, Howlett, T, Levy, M, Orme, S, Akker, SA, Abel, R, Grossman, AB, Burger, J, Ellard, S, Korbonits, M
Format:	Journal article
Idioma:	English
Publicat:	2011

Ítems similars

Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.
per: Chahal, H, et al.
Publicat: (2011)

Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
per: Igreja, S, et al.
Publicat: (2010)

The Pathogenic Role of AIP Mutations - The Importance of the Integration of Clinical, Experimental and Modeling Data on Advising Patients and Their Families with Pituitary Adenoma Predisposition.
per: Trivellin, G, et al.
Publicat: (2010)

Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort.
per: Preda, V, et al.
Publicat: (2014)

Novel molecular aspects of pituitary adenomas.
per: Hubina, E, et al.
Publicat: (2005)

The pathology of pituitary adenomas from a clinical perspective.
per: Dworakowska, D, et al.
Publicat: (2011)

Oncogene-induced senescence in pituitary adenomas and carcinomas.
per: Alexandraki, K, et al.
Publicat: (2012)

Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
per: Chahal, H, et al.
Publicat: (2012)

The pathophysiology of pituitary adenomas.
per: Dworakowska, D, et al.
Publicat: (2009)

The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.
per: Lloyd, C, et al.
Publicat: (2014)

The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas
per: Lloyd, C, et al.
Publicat: (2014)

AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center
per: Adrian F Daly, et al.
Publicat: (2019-03-01)

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
per: Chahal, H, et al.
Publicat: (2010)

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
per: Morris, D, et al.
Publicat: (2005)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
per: Korbonits, M, et al.
Publicat: (2001)

The release of leptin and its effect on hormone release from human pituitary adenomas.
per: Korbonits, M, et al.
Publicat: (2001)

Akting and cycling: a tale of the pituitary.
per: Grossman, AB, et al.
Publicat: (2004)

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
per: Korbonits, M, et al.
Publicat: (1998)

Emergence of Pituitary Adenoma in a Child during Surveillance: Clinical Challenges and the Family Members’ View in an AIP Mutation-Positive Family
per: Pedro Marques, et al.
Publicat: (2018-01-01)

AIP Mediates the Effects of Somatostatin Analogues in Acromegaly - Evidence from Clinical and Experimental Studies.
per: Chahal, H, et al.
Publicat: (2010)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
per: Korbonits, M, et al.
Publicat: (1999)

Increased population risk of AIP-related acromegaly and gigantism in Ireland.
per: Radian, S, et al.
Publicat: (2016)

Metabolic changes in patients with familial pituitary adenomas associated with mutations in the AIP gene
per: Tatiana S. Tarasova, et al.
Publicat: (2017-03-01)

A mutation and expression analysis of the oncogene BRAF in pituitary adenomas.
per: Ewing, I, et al.
Publicat: (2007)

MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
per: Trivellin, G, et al.
Publicat: (2012)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
per: Korbonits, M, et al.
Publicat: (1995)

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro.
per: Chahal, H, et al.
Publicat: (2011)

Cyclins and their related proteins in pituitary tumourigenesis.
per: Muşat, M, et al.
Publicat: (2010)

Second brain tumour after treatment for pituitary adenoma.
per: Wass, J, et al.
Publicat: (1992)

Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
per: Morris, D, et al.
Publicat: (2003)

Presence of ghrelin in normal and adenomatous human pituitary.
per: Korbonits, M, et al.
Publicat: (2001)

Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
per: Pyle, M, et al.
Publicat: (2003)

Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
per: Igreja, S, et al.
Publicat: (2009)

Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.
per: Skelly, R, et al.
Publicat: (2000)

Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma.
per: Allan, C, et al.
Publicat: (2001)

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
per: Korbonits, M, et al.
Publicat: (1999)

Role of regulatory factors in pituitary tumour formation.
per: Korbonits, M, et al.
Publicat: (2004)

Cyclin D and cyclin E expression in normal and adenomatous pituitary.
per: Jordan, S, et al.
Publicat: (2000)

Cell cycle dysregulation in pituitary oncogenesis.
per: Muşat, M, et al.
Publicat: (2004)

The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
per: Aylwin, S, et al.
Publicat: (2001)